This paper builds a mathematical model that treats exposure in the classic public‑health sense: an exposed person has had a potentially infectious contact, but may or may not have become infected. The authors add a simple way to track where an exposure came from and how far along an infected person is in their infection. That lets the model link the dose received in a contact and the infectious person’s viral load to the chance that exposure actually leads to infection.

The model splits the population into familiar groups — susceptible, exposed, infected (symptomatic and asymptomatic), and recovered — but with extra detail. Each infected class is subdivided into n stages to represent a discrete “age of infection.” These stages act as a proxy for viral load: early stages represent low viral load, later stages higher viral load. For every infected stage there is a matching exposed compartment that records exposures coming from that specific stage. New exposures enter EXk at rate c_Xk X_k S / N, where c_Xk is a contact rate for stage k and X_k is the number of infectious people in that stage. The total force of exposure is the sum of contact rates times infectious numbers divided by population size, i.e., λ_exp = (sum_k c^I_k I_k + sum_k c^A_k A_k)/N. After spending on average 1/ε_Xk time in EXk, an exposed person either becomes infected with probability δ_Xk or returns to susceptible. Of those who become infected, a source‑dependent fraction π_Xk become symptomatic and the rest asymptomatic. The model also includes transitions from asymptomatic to symptomatic (presymptomatic progression), recovery with temporary immunity, natural deaths, and disease‑induced deaths that can depend on infection stage.

Why this matters: many standard models call the latent, already‑infected state “exposed,” which mixes up two different ideas. The authors point out that confusing a contact with confirmed infection can lead to mistakes, for example when estimating the benefit of contact screening and isolation. By keeping exposure (a contact event) separate from infection, and by tracking the infectious stage of the source, the model can represent how the viral dose and source stage change the chance of transmission. That makes it easier to study interventions such as contact tracing, isolation, and their true costs and benefits.